The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Systemic cytokine dynamics during neoadjuvant chemotherapy versus endocrine therapy and CDK4/6 inhibition in high-risk luminal breast cancer: Results from the GEICAM/2019-01-CARABELA trial.
 
Angel Guerrero-Zotano
Consulting or Advisory Role - Exact Sciences; Novartis; Pierre Fabre; Roche
Speakers' Bureau - AstraZeneca; Lilly; Menarini; Novartis
Expert Testimony - AstraZeneca; Lilly; Menarini; Novartis; Pfizer; Pierre Fabre
Travel, Accommodations, Expenses - Gilead Sciences; Menarini; Novartis; Roche
 
Miguel Martin
Stock and Other Ownership Interests - AstraZeneca; Pfizer
Honoraria - Lilly; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; SEAGEN
Consulting or Advisory Role - AstraZeneca; Daiichi-Sankyo; Lilly; Novartis; Pfizer; Roche/Genentech; ROVI Spain; STEMLINE-MENARINI
Speakers' Bureau - Lilly/ImClone; Lilly/ImClone; Pierre Fabre; Roche/Genentech
Research Funding - Novartis (Inst); Puma Biotechnology (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Daichii-Sankyo
Other Relationship - AstraZeneca; Novartis; Roche
 
Maria Eva Perez-Lopez
No Relationships to Disclose
 
Noelia Martinez-Jañez
No Relationships to Disclose
 
Juan David Cardenas
No Relationships to Disclose
 
Miguel Gil Gil
Honoraria - AstraZeneca; Daiichi-Sankyo; Esteve Ph.; Lilly; Menarini Stemline Spain; Pfizer
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Lilly; Novartis; Pfizer
 
Manuel Ruiz-Borrego
Honoraria - Novartis; pfizer; Roche/Genentech
Consulting or Advisory Role - Puma Biotechnology; Roche
 
Pedro Sanchez-Rovira
No Relationships to Disclose
 
Sonia Del Barco
No Relationships to Disclose
 
Begoña Bermejo
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Gilead Sciences; Lilly; Menarini; MSD Oncology; Novartis; Pfizer; Roche/Genentech
Speakers' Bureau - AstraZeneca/Daiichi Sankyo; Gilead Sciences; Lilly; MSD Oncology; Novartis/Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche/Genentech
 
Raquel Andrés
Consulting or Advisory Role - Lilly; Lilly; seagen
Speakers' Bureau - daichi; Lilly; Novartis; Pfizer; Pierre Fabre
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca; MSD Oncology; Pierre Fabre
 
Jose Ponce-Lorenzo
Honoraria - Agendia; AstraZeneca/Daiichi Sankyo; Gilead Sciences; Lilly; Novartis; Pfizer; Seagen
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Novartis; Pierre Fabré; Roche; Seagen
 
Eduardo Martínez-De Dueñas
No Relationships to Disclose
 
Jesús Herranz
No Relationships to Disclose
 
Rosalia Caballero
No Relationships to Disclose
 
Marta Portela
No Relationships to Disclose
 
Mari­a M. Caffarel
No Relationships to Disclose
 
Federico Rojo
Honoraria - Abbvie; AstraZeneca; BMS GmbH & Co. KG; GlaxoSmithKline; Lilly; Menarini; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - Abbvie; Agilent; Bristol-Myers Squibb; Genomic Health; Guardant Health; Merck Sharp & Dohme; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); Pfizer; Roche/Genentech; Stemline Therapeutics (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Maria Jose Lallena
No Relationships to Disclose
 
Emilio Alba
Consulting or Advisory Role - Bristol-Myers Squibb; Exact Sciences; Lilly; Novartis; Pfizer
Research Funding - AstraZeneca (Inst); Pfizer (Inst)